Medford, MA, United States of America

Alice Loo



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Alice Loo

Introduction: Alice Loo, an accomplished inventor based in Medford, MA, has made significant strides in the pharmaceutical industry. With a focus on improving treatments for proliferative diseases, her innovative work is reflected in her patent, showcasing her dedication to advancing healthcare solutions.

Latest Patents: Alice Loo holds a patent for "Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor." This patent encompasses a pharmaceutical combination that includes a CDK4/6 inhibitor, a B-Raf inhibitor, and optionally a MEK 1/2 inhibitor. It details combined preparations and pharmaceutical compositions, as well as the uses of this combination in treating proliferative diseases. Moreover, it outlines methods for treating subjects suffering from such diseases by administering a therapeutically effective amount of these combinations.

Career Highlights: Alice has made her mark at Novartis AG, a leading global healthcare company. Her work is not only pivotal in the realm of pharmaceuticals but also exemplifies her role as a frontrunner in innovative medical treatments.

Collaborations: Throughout her career, Alice has collaborated with esteemed colleagues such as Giordano Caponigro and Darrin Stuart. These partnerships have enhanced her research capabilities and contributed to her success as an inventor in the pharmaceutical industry.

Conclusion: Alice Loo's achievements as an inventor illustrate her vital contributions to medicine and the ongoing pursuit of effective treatment methods for proliferative diseases. Her innovative patent reflects her commitment to harnessing science for the betterment of health outcomes, setting an inspiring example for future inventors in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…